Tags

Type your tag names separated by a space and hit enter

Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine.
Vaccine. 2006 Aug 14; 24(33-34):5960-5.V

Abstract

BACKGROUND

This study was undertaken to analyse the epidemiology of pertussis disease among hospitalised children during the transition period from whole-cell to acellular pertussis vaccine in order to compare the respective estimates of vaccine effectiveness.

METHODS

Surveillance was conducted between 1 January 1996 and 31 December 2003. The data originated from a voluntary hospital-based surveillance network including all 44 nationwide paediatric departments.

RESULTS

The mean annual hospitalisation incidence for children decreased over time, from 27.9 per 100,000 population in 1996 to 6.8 cases per 100,000 population in 2003. The mean age of reported hospitalised pertussis cases was 4.7 years (+/- 5.5 S.D.), increasing from 4.06 years (+/- 4.6 S.D.) in 1996 to 5.5 years (+/- 8.6 S.D.) in 2003. Estimated vaccine effectiveness (after three vaccine doses) was 79% for the whole-cell versus 92% for the acellular pertussis vaccine. A significantly higher proportion (19%) of fully immunised children among hospitalised patients was observed for the years where only acellular pertussis vaccine was used compared to whole-cell vaccine era (2%) which was, however, mainly due to children above 2 years of age.

CONCLUSIONS

Our results imply that despite high vaccination coverage rate, pertussis is still a considerable cause of hospital admissions in children in Austria where it remains to be shown that the novel vaccination strategy of additional booster doses in adolescents and adults will control disease in the long term.

Authors+Show Affiliations

Department of Specific Prophylaxis and Tropical Medicine, Centre for Physiology and Pathophysiology, Medical University Vienna, Kinderspitalgasse 15, A-1090 Vienna, Austria. pamela.rendi-wagner@meduniwien.ac.atNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16757063

Citation

Rendi-Wagner, Pamela, et al. "Hospital-based Active Surveillance of Childhood Pertussis in Austria From 1996 to 2003: Estimates of Incidence and Vaccine Effectiveness of Whole-cell and Acellular Vaccine." Vaccine, vol. 24, no. 33-34, 2006, pp. 5960-5.
Rendi-Wagner P, Kundi M, Mikolasek A, et al. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine. 2006;24(33-34):5960-5.
Rendi-Wagner, P., Kundi, M., Mikolasek, A., Vécsei, A., Frühwirth, M., & Kollaritsch, H. (2006). Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine, 24(33-34), 5960-5.
Rendi-Wagner P, et al. Hospital-based Active Surveillance of Childhood Pertussis in Austria From 1996 to 2003: Estimates of Incidence and Vaccine Effectiveness of Whole-cell and Acellular Vaccine. Vaccine. 2006 Aug 14;24(33-34):5960-5. PubMed PMID: 16757063.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. AU - Rendi-Wagner,Pamela, AU - Kundi,Michael, AU - Mikolasek,Andrea, AU - Vécsei,Andreas, AU - Frühwirth,Martin, AU - Kollaritsch,Herwig, Y1 - 2006/05/23/ PY - 2005/07/05/received PY - 2006/03/10/revised PY - 2006/05/09/accepted PY - 2006/6/8/pubmed PY - 2006/11/14/medline PY - 2006/6/8/entrez SP - 5960 EP - 5 JF - Vaccine JO - Vaccine VL - 24 IS - 33-34 N2 - BACKGROUND: This study was undertaken to analyse the epidemiology of pertussis disease among hospitalised children during the transition period from whole-cell to acellular pertussis vaccine in order to compare the respective estimates of vaccine effectiveness. METHODS: Surveillance was conducted between 1 January 1996 and 31 December 2003. The data originated from a voluntary hospital-based surveillance network including all 44 nationwide paediatric departments. RESULTS: The mean annual hospitalisation incidence for children decreased over time, from 27.9 per 100,000 population in 1996 to 6.8 cases per 100,000 population in 2003. The mean age of reported hospitalised pertussis cases was 4.7 years (+/- 5.5 S.D.), increasing from 4.06 years (+/- 4.6 S.D.) in 1996 to 5.5 years (+/- 8.6 S.D.) in 2003. Estimated vaccine effectiveness (after three vaccine doses) was 79% for the whole-cell versus 92% for the acellular pertussis vaccine. A significantly higher proportion (19%) of fully immunised children among hospitalised patients was observed for the years where only acellular pertussis vaccine was used compared to whole-cell vaccine era (2%) which was, however, mainly due to children above 2 years of age. CONCLUSIONS: Our results imply that despite high vaccination coverage rate, pertussis is still a considerable cause of hospital admissions in children in Austria where it remains to be shown that the novel vaccination strategy of additional booster doses in adolescents and adults will control disease in the long term. SN - 0264-410X UR - https://www.unboundmedicine.com/medline/citation/16757063/Hospital_based_active_surveillance_of_childhood_pertussis_in_Austria_from_1996_to_2003:_estimates_of_incidence_and_vaccine_effectiveness_of_whole_cell_and_acellular_vaccine_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(06)00548-2 DB - PRIME DP - Unbound Medicine ER -